StockWatch
·
Specialty Chemicals
Board Meeting28 Oct 2026, 12:56 pm

Consolidated PAT surges ~6.9x YoY to ₹33.7 Cr on 90% revenue growth; margin eases QoQ

AI Summary

Yasho Industries' consolidated PAT came in at ₹33.68 Cr for Q2 FY27, up ~5.9x YoY from ₹4.86 Cr, on consolidated revenue of ₹347.68 Cr, up 89.7% YoY from ₹183.30 Cr — a continuation of the volume-led ramp the company flagged on its Q1 call (42% volume growth, better capacity utilisation, favorable mix). No reliable street/consensus estimate for this specific quarter could be sourced, so the print is assessed against the company's own guidance rather than a street number. Standalone PAT grew even faster YoY (+968%, ₹2.87 Cr to ₹30.65 Cr) than consolidated (+593%) because the year-ago quarter's subsidiary contribution was proportionally larger than this quarter's — the headline consolidated number is the more complete read, but readers comparing to standalone should expect a steeper YoY jump there. Sequentially, growth continued (revenue +13.0% QoQ versus Q1 FY27's ₹307.74 Cr) but profitability eased: PAT fell 6.6% QoQ from Q1's record ₹36.05 Cr, and OPM (EBITDA/revenue) slipped to 20.90% from 23.75% in Q1 (reported as 24.2% EBITDA margin on the Q1 call). NPM still expanded sharply YoY, from 2.65% to 9.69%, so the YoY margin story remains one of expansion — the QoQ dip reads as normalization off an unusually strong Q1 base rather than a deterioration, since this is a specialty-chemicals business with no obvious seasonal driver. On guidance: revenue growth of 90% YoY is far ahead of management's targeted 30-40% annual growth band, a clear beat on that front. Capex execution also tracks the raised FY27 target of ₹250 Cr for the two Pakhajan production buildings — ₹131.29 Cr was already deployed in H1 FY27 (capital work-in-progress rose from ₹10.04 Cr at FY26-end to ₹131.05 Cr), roughly half the full-year budget spent in the first half. The one guidance metric this quarter missed is margin: management's stated endeavor to maintain ~24% EBITDA margin wasn't met, with OPM at 20.90% versus Q1's 24.2%. No management press release was available for this result to cross-check commentary against the print, and the quarter's corporate-action record shows only the standard results-cycle events (trading window closure, board meeting notice) — no incremental deal or capacity announcements beyond the ongoing Pakhajan capex already reflected in the balance sheet.

Key Highlights

  • Consolidated revenue ₹347.68 Cr, +89.7% YoY (₹183.30 Cr) and +13.0% QoQ (₹307.74 Cr), on continued volume/export-led growth.
  • Consolidated PAT ₹33.68 Cr, up ~5.9x YoY (₹4.86 Cr) but down 6.6% QoQ from Q1 FY27's record ₹36.05 Cr.
  • NPM expanded to 9.69% from 2.65% YoY; OPM eased to 20.90% from Q1's 23.75% (24.2% as reported), below management's ~24% EBITDA margin endeavor.
  • Standalone PAT ₹30.65 Cr on revenue ₹336.37 Cr grew even faster YoY (+968%) than consolidated (+593%) due to a smaller year-ago base.
  • ₹131.29 Cr of FY27 capex already deployed in H1 (CWIP up to ₹131.05 Cr from ₹10.04 Cr at FY26-end) against the raised ₹250 Cr full-year Pakhajan capex target.
  • EPS (basic, consolidated) ₹27.93 for the quarter vs ₹4.03 a year ago and ₹29.90 last quarter.
  • No exceptional items in either the current or year-ago quarter — growth is entirely operational, not one-off driven.